Besides ‘molecular mechanisms of cancer’, LMTK2 was also shown to regulate B cell receptor signaling, HGF signaling, PI3K signaling in B lymphocytes, IGF-1 signaling and senescence pathways, all of which have been previously described to play a role in cancer development (34–38). This evidence concerns the gene HGF and cancer.